Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors.
Lechner K, von Schacky C, McKenzie AL, Worm N, Nixdorff U, Lechner B, Kränkel N, Halle M, Krauss RM, Scherr J.
Eur J Prev Cardiol. 2020 Mar;27(4):394-406. doi: 10.1177/2047487319869400. Epub 2019 Aug 13.
Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies.
Rees MJ, D'Agostino M, Leypoldt LB, Kumar S, Weisel KC, Gay F.
Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e433520. doi: 10.1200/EDBK_433520.
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group.
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
Risk and protective factors of drug abuse among adolescents: a systematic review.
Nawi AM, Ismail R, Ibrahim F, Hassan MR, Manaf MRA, Amit N, Ibrahim N, Shafurdin NS.
BMC Public Health. 2021 Nov 13;21(1):2088. doi: 10.1186/s12889-021-11906-2.
High-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment: Exploring and Explaining the "U"-Shaped Curve.
Razavi AC, Mehta A, Jain V, Patel P, Liu C, Patel N, Eisenberg S, Vaccarino V, Isiadinso I, Sperling LS, Quyyumi AA.
Curr Cardiol Rep. 2023 Dec;25(12):1725-1733. doi: 10.1007/s11886-023-01987-3. Epub 2023 Nov 16.
Lipoprotein(a) and cardiovascular disease.
Nordestgaard BG, Langsted A.
Lancet. 2024 Sep 28;404(10459):1255-1264. doi: 10.1016/S0140-6736(24)01308-4. Epub 2024 Sep 12.
Early Cerebral Palsy Detection and Intervention.
Mendoza-Sengco P, Lee Chicoine C, Vargus-Adams J.
Pediatr Clin North Am. 2023 Jun;70(3):385-398. doi: 10.1016/j.pcl.2023.01.014. Epub 2023 Mar 21.
Assessing Cardiovascular Risk in Patients with Diabetes: An Update.
Damaskos C, Garmpis N, Kollia P, Mitsiopoulos G, Barlampa D, Drosos A, Patsouras A, Gravvanis N, Antoniou V, Litos A, Diamantis E.
Curr Cardiol Rev. 2020;16(4):266-274. doi: 10.2174/1573403X15666191111123622.
Evaluation of high-risk living kidney donors.
Tangdhanakanond K, Mandelbrot D.
Front Biosci (Elite Ed). 2015 Jan 1;7(1):158-67. doi: 10.2741/725.
Communicating about risk: strategies for situations where public concern is high but the risk is low.
Hooker C, Capon A, Leask J.
Public Health Res Pract. 2017 Jan 15;27(1):2711709. doi: 10.17061/phrp2711709.
